Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Authorization symbols : GLAXF save search
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
Published: 2022-03-25 (Crawled : 21:00) - biospace.com/
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 4.57%
H: 0.0%
C: -3.26%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
XNCR | $19.02 3.54% 3.57% 760K
|
Health Technology
|
| O: -0.7%
H: 1.94%
C: -1.47%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: -1.07%
H: 0.8%
C: -12.62%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
drug food authorization emergency use authorization
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
XNCR | $19.02 3.54% 3.57% 760K
|
Health Technology
|
| O: 0.38%
H: 1.12%
C: -1.31%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 1.05%
H: 1.98%
C: -6.88%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 2.36%
H: 0.46%
C: 0.46%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
XNCR | $19.02 3.54% 3.57% 760K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: -4.59%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
covid-19 treatment europe granted covid authorization grant
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.